Phase I study of amrubicin and cisplatin in previously untreated patients with advanced non-small-cell lung cancer

被引：2
|
作者：
Yoshimura, N.
Kudoh, S.
Kimura, T.
Mitsuoka, S.
Yana, T.
Hirata, K.
机构：
[1] Otemae Hosp, Osaka, Japan
[2] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19119
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
    Millward, MJ
    Zalcberg, J
    Bishop, JF
    Webster, LK
    Zimet, A
    Rischin, D
    Toner, GC
    Laird, J
    Cosolo, W
    Urch, M
    Bruno, R
    Loret, C
    James, R
    Blanc, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 750 - 758
  • [2] Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer
    Hotta, K
    Takigawa, N
    Kiura, K
    Tabata, M
    Umemura, S
    Ogino, A
    Uchida, A
    Bessho, A
    Segawa, Y
    Shinkai, T
    Nogami, N
    Harita, S
    Okimoto, N
    Ueoka, H
    Tanimoto, M
    [J]. ANTICANCER RESEARCH, 2005, 25 (3C) : 2429 - 2434
  • [3] Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer
    Ikeda, J
    Maruyama, R
    Okamoto, T
    Shoji, F
    Wataya, H
    Ichinose, Y
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 12 - 16
  • [4] Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.
    Kiura, K
    Hotta, K
    Takigawa, N
    Bessho, A
    Harita, S
    Umemura, S
    Ogino, A
    Tabata, M
    Ueoka, H
    Tanimoto, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 699S - 699S
  • [5] Dose Escalation and Feasibility Study of Amrubicin Combined With Cisplatin in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
    Yoshimura, Naruo
    Kimura, Tatsuo
    Mitsuoka, Shigeki
    Kyoh, Shigenori
    Tochino, Yoshihiro
    Asai, Kazuhisa
    Ichimaru, Yukikazu
    Hirata, Kazuto
    Kudoh, Shinzoh
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (02): : 105 - 109
  • [6] Phase I study of docetaxel and cisplatin for patients with previously untreated metastatic non-small-cell lung cancer: A Japanese cooperative study
    Segawa Y.
    Watanabe K.
    Hiraki S.
    Tominaga K.
    Hayashi I.
    Harada M.
    Yamakido M.
    Ueda N.
    Kashimura M.
    Niitani H.
    [J]. International Journal of Clinical Oncology, 2000, 5 (5) : 308 - 315
  • [7] Phase II study of docetaxel and cisplatin in patients with previously untreated metastatic non-small-cell lung cancer
    Okamoto H.
    Watanabe K.
    Segawa Y.
    Ichinose Y.
    Yokoyama A.
    Yoneda S.
    Niitani H.
    [J]. International Journal of Clinical Oncology, 2000, 5 (5) : 316 - 322
  • [8] Topotecan in combination with cisplatin in patients with previously untreated non-small-cell lung carcinoma. A phase I study
    Raymond, E
    Burris, HA
    Rowinsky, EK
    Eckardt, JR
    Rodriguez, G
    Smith, L
    Weiss, G
    Von Hoff, DD
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 70 - 70
  • [9] Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer
    Ogawara, Daiki
    Nakamura, Yoichi
    Fukuda, Minoru
    Nakatomi, Katsumi
    Yamaguchi, Hiroyuki
    Motoshima, Kohei
    Mizoguchi, Kosuke
    Nakano, Hirofumi
    Takemoto, Shinnosuke
    Gyotoku, Hiroshi
    Nagashima, Seiji
    Kohno, Shigeru
    [J]. CHEMOTHERAPY, 2014, 60 (03): : 180 - 184
  • [10] Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy
    PerezSoler, R
    Fossella, FV
    Glisson, BS
    Lee, JS
    Murphy, WK
    Shin, DM
    Kemp, BL
    Lee, JJ
    Kane, J
    Robinson, RA
    Lippman, SM
    Kurie, JM
    Huber, MH
    Raber, MN
    Hong, WK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 503 - 513
12345